Cargando…

Atrial fibrillation after vaccination for COVID-19: analysis of the vaccine adverse event reporting system

Detalles Bibliográficos
Autores principales:	Kumar, Ashish, Shariff, Mariam, Bhat, Vivek, DeSimone, Christopher, Deshmukh, Abhishek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175153/ https://www.ncbi.nlm.nih.gov/pubmed/35674855 http://dx.doi.org/10.1007/s10840-022-01263-4

Ejemplares similares

Remote ischemic preconditioning and its role in the prevention of new onset atrial fibrillation post‐cardiac surgery. A meta‐analysis of randomized control trials
por: Kumar, Ashish, et al.
Publicado: (2019)

One-year outcomes of catheter ablation for atrial fibrillation in young patients
por: Tseng, Andrew S., et al.
Publicado: (2023)

Association of atrial fibrillation and outcomes in patients undergoing bone marrow transplantation
por: Krishan, Satyam, et al.
Publicado: (2023)

Safety and efficacy outcomes of atrial fibrillation ablation in patients with rheumatoid arthritis
por: Haq, Ikram U., et al.
Publicado: (2022)

Left atrial dissection as a trigger for recurrent atrial fibrillation
por: Kashou, Anthony H., et al.
Publicado: (2020)

VACCINE ASSOCIATED ATRIAL FIBRILLATION
por: Ghoweba, Mohamed, et al.
Publicado: (2022)

Catheter ablation of atrial fibrillation in patients with and without hypertrophic cardiomyopathy: systematic review and meta-analysis
por: Ezzeddine, Fatima M, et al.
Publicado: (2023)

Ocular Complications after COVID-19 Vaccination, Vaccine Adverse Event Reporting System
por: Nyankerh, Cyril N. A., et al.
Publicado: (2022)

Impact of Atrial Fibrillation on Outcomes in Patients Hospitalized With Nontraumatic Intracerebral Hemorrhage
por: Thotamgari, Sahith Reddy, et al.
Publicado: (2023)

Adverse Events After COVID-19 Vaccination
Publicado: (2022)

COVID MRNA VACCINATION AND RISK OF HOSPITALIZATION FOR ATRIAL FIBRILLATION
por: Lee, Ming Sum, et al.
Publicado: (2023)

Vaccine-Associated Uveitis after COVID-19 Vaccination: Vaccine Adverse Event Reporting System Database Analysis
por: Singh, Rohan Bir, et al.
Publicado: (2023)

Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation
por: Lee, So-Ryoung, et al.
Publicado: (2022)

SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system
por: Bonora, Benedetta Maria, et al.
Publicado: (2021)

Cutaneous Adverse Events After COVID-19 Vaccination
por: Weschawalit, Sinee, et al.
Publicado: (2023)

Adverse Events Following Immunization Associated with Coronavirus Disease 2019 Vaccination Reported in the Mobile Vaccine Adverse Events Reporting System
por: Jeon, Minji, et al.
Publicado: (2021)

Trends in Human Papillomavirus Vaccine Safety Concerns and Adverse Event Reporting in the United States
por: Sonawane, Kalyani, et al.
Publicado: (2021)

Outcomes and Resource Utilization Associated With Readmissions After Atrial Fibrillation Hospitalizations
por: Tripathi, Byomesh, et al.
Publicado: (2019)

Comparison of procedural outcomes in patients undergoing catheter vs surgical ablation for atrial fibrillation and heart failure with reduced ejection fraction
por: Doshi, Rajkumar, et al.
Publicado: (2020)

Chronic kidney disease and risks of adverse clinical events in patients with atrial fibrillation
por: LI, Si-Tong, et al.
Publicado: (2021)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Homoarginine Associates with Carotid Intima-Media Thickness and Atrial Fibrillation and Predicts Adverse Events after Stroke
por: Schwieren, Laura, et al.
Publicado: (2023)

Human papillomavirus vaccine-associated premature ovarian insufficiency and related adverse events: data mining of Vaccine Adverse Event Reporting System
por: Gong, Li, et al.
Publicado: (2020)

Atrial fibrillation ablation in end-stage renal Disease:...Yes, we can!
por: Kowlgi, Gurukripa N., et al.
Publicado: (2021)

Frequency of Adverse Events after Vaccination with Different Vaccinia Strains
por: Kretzschmar, Mirjam, et al.
Publicado: (2006)

Characteristics and outcomes of adverse events after COVID‐19 vaccination
por: Kewan, Tariq, et al.
Publicado: (2021)

Cardiac Adverse Events after Vaccination—A Systematic Review
por: Parmar, Kanak, et al.
Publicado: (2022)

Ocular Adverse Events after Inactivated COVID-19 Vaccination
por: Li, Zhihua, et al.
Publicado: (2022)

Summary of COVID-19 Vaccine-Related Reports in the Vaccine Adverse Event Reporting System
por: Ceacareanu, Alice C., et al.
Publicado: (2021)

Pregnancy safety of COVID-19 vaccines is validated by the Vaccine Adverse Event Reporting System
por: Grunebaum, Amos, et al.
Publicado: (2022)

Healthcare utilization and costs associated with a diagnosis of incident atrial fibrillation
por: Deshmukh, Abhishek, et al.
Publicado: (2022)

Central nervous system adverse events after ChAdOx1 vaccination
por: Maramattom, Boby Varkey, et al.
Publicado: (2022)

1077 Adverse events following measles, mumps, and rubella (MMR) vaccine in adults reported to the Vaccine Adverse Event Reporting System, 2003-2013
por: Sukumaran, Lakshmi, et al.
Publicado: (2014)

Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case–control assessment of the vaccine adverse event reporting system (VAERS) database
por: Geier, David A., et al.
Publicado: (2016)

Atrial Fibrillation as a Risk Factor for Major Adverse Cardiac and Cerebrovascular Events after Non-cardiac Surgery
por: Shin, Dong Geum, et al.
Publicado: (2020)

Thrombocytopenia after Ad.26.COV2.S COVID-19 vaccine: Reports to the vaccine adverse event reporting system
por: Woo, Emily Jane, et al.
Publicado: (2022)

Plasma Asymmetric Dimethylarginine and Adverse Events in Patients with Atrial Fibrillation Referred for Coronary Angiogram
por: Chao, Tze-Fan, et al.
Publicado: (2013)

Newly Diagnosed Atrial Fibrillation Is an Independent Factor for Future Major Adverse Cardiovascular Events
por: Li, Chen-Yu, et al.
Publicado: (2015)

Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials
por: Brown, Jennifer R., et al.
Publicado: (2017)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q3ronejnhsnfs82j0ov52r5dnh